Skip to main content

ORIGINAL RESEARCH article

Front. Pharmacol.
Sec. Neuropharmacology
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1536438
This article is part of the Research Topic Model Organisms in Neuropharmacology 2024 View all articles

Impact of Fluoxetine Exposure on Lymnaea stagnalis and Its Developing Eggs: Integrating Untargeted Lipidomics, Targeted Metabolomics, and Classical Risk Assessment

Provisionally accepted
  • 1 VU Amsterdam, Amsterdam, Netherlands
  • 2 Senckenberg Research Institute and Natural History Museum Frankfurt, Frankfurt, Hesse, Germany

The final, formatted version of the article will be published soon.

    Pharmaceuticals such as selective serotonin reuptake inhibitors (SSRIs), are increasingly detected in aquatic environments, posing potential risks to non-target organisms, because many of those substances are widely shared neuromodulator. In this study, we investigated the effects of SSRI antidepressant, namely fluoxetine, exposure on the freshwater snail Lymnaea stagnalis, focusing on egg development, neurochemical pathways, and lipid metabolism. Snails were exposed to a range of 51 to 434 µg fluoxetine L⁻¹ for seven days, followed by analysis of survival, feeding behaviour, reproduction, and metabolomic changes in the central nervous system (CNS), albumen gland, and eggs. Although no significant effects were observed on survival or fecundity, fluoxetine exposure significantly impaired egg development in a dose-dependent manner, reducing hatching rates with an EC50 of 126 µg fluoxetine L⁻¹. Removal of eggs from the contaminated environment partially reversed these developmental effects, suggesting potential recovery if fluoxetine levels decrease. Molecular analysis revealed several neurochemical and lipidomic alterations. In the CNS, elevated levels of catecholamines, phosphatidylcholines (PC), and ceramides were linked to disruptions in neurotransmission, membrane integrity, and impaired embryo development. In the albumen gland, we detected a decrease of key lipid classes, including sphingomyelins and fatty acids, which can be linked with impaired egg quality. Additionally, a decrease in histamine in both the albumen gland and eggs suggested further disruption of egg development, potentially affecting metamorphosis success. Moreover, the dose-dependent increase in choline, along with PC and oxidized PC, indicated oxidative stress and lipid peroxidation in the CNS and exposed eggs of L. stagnalis. Our findings highlight the benefits of combining behavioral assessments with metabolomic profiling to better understand the mechanistic pathways underlying fluoxetine's adverse effects.

    Keywords: Fluoxetine exposure, Lymnaea stagnalis, Lipid metabolism, Egg development, Ecotoxicology, Metabolomic profiling, Neurochemical pathways ACN, acetonitrile, ANOVA, analysis of variance, BA, bile acids, BMC, benchmark concentrations, BMP, bismonoacylglycerophosphates, BPUs, benzoylphenylureas, CAR, acylcarnitines, CE, cholesteryl esters

    Received: 28 Nov 2024; Accepted: 17 Jan 2025.

    Copyright: © 2025 Ilyaskina, Nakadera, Lamoree, Koene and Leonards. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Pim Leonards, VU Amsterdam, Amsterdam, Netherlands

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.